These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 36107167)

  • 1. Growth parameters in children with achondroplasia: A 7-year, prospective, multinational, observational study.
    Savarirayan R; Irving M; Harmatz P; Delgado B; Wilcox WR; Philips J; Owen N; Bacino CA; Tofts L; Charrow J; Polgreen LE; Hoover-Fong J; Arundel P; Ginebreda I; Saal HM; Basel D; Font RU; Ozono K; Bober MB; Cormier-Daire V; Le Quan Sang KH; Baujat G; Alanay Y; Rutsch F; Hoernschemeyer D; Mohnike K; Mochizuki H; Tajima A; Kotani Y; Weaver DD; White KK; Army C; Larrimore K; Gregg K; Jeha G; Milligan C; Fisheleva E; Huntsman-Labed A; Day J
    Genet Med; 2022 Dec; 24(12):2444-2452. PubMed ID: 36107167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Height growth velocity during infancy and childhood in achondroplasia.
    Del Pino M; Fano V; Adamo P
    Am J Med Genet A; 2019 Jun; 179(6):1001-1009. PubMed ID: 30888098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth velocity and biological variables during puberty in achondroplasia.
    Del Pino M; Fano V; Adamo P
    J Pediatr Endocrinol Metab; 2018 Mar; 31(4):421-428. PubMed ID: 29466240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth in achondroplasia, from birth to adulthood, analysed by the JPA-2 model.
    Del Pino M; Fano V; Adamo P
    J Pediatr Endocrinol Metab; 2020 Dec; 33(12):1589-1595. PubMed ID: 33180038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safe and persistent growth-promoting effects of vosoritide in children with achondroplasia: 2-year results from an open-label, phase 3 extension study.
    Savarirayan R; Tofts L; Irving M; Wilcox WR; Bacino CA; Hoover-Fong J; Font RU; Harmatz P; Rutsch F; Bober MB; Polgreen LE; Ginebreda I; Mohnike K; Charrow J; Hoernschemeyer D; Ozono K; Alanay Y; Arundel P; Kotani Y; Yasui N; White KK; Saal HM; Leiva-Gea A; Luna-González F; Mochizuki H; Basel D; Porco DM; Jayaram K; Fisheleva E; Huntsman-Labed A; Day JRS
    Genet Med; 2021 Dec; 23(12):2443-2447. PubMed ID: 34341520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leg length, sitting height, and body proportions references for achondroplasia: New tools for monitoring growth.
    Del Pino M; Ramos Mejía R; Fano V
    Am J Med Genet A; 2018 Apr; 176(4):896-906. PubMed ID: 29424094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Exploring the clinical genetic characteristics and height for age growth curve of 210 patients with achondroplasia in China].
    Dai WQ; Gu XF; Yu YG
    Zhonghua Er Ke Za Zhi; 2020 Jun; 58(6):461-467. PubMed ID: 32521957
    [No Abstract]   [Full Text] [Related]  

  • 8. Once-daily, subcutaneous vosoritide therapy in children with achondroplasia: a randomised, double-blind, phase 3, placebo-controlled, multicentre trial.
    Savarirayan R; Tofts L; Irving M; Wilcox W; Bacino CA; Hoover-Fong J; Ullot Font R; Harmatz P; Rutsch F; Bober MB; Polgreen LE; Ginebreda I; Mohnike K; Charrow J; Hoernschemeyer D; Ozono K; Alanay Y; Arundel P; Kagami S; Yasui N; White KK; Saal HM; Leiva-Gea A; Luna-González F; Mochizuki H; Basel D; Porco DM; Jayaram K; Fisheleva E; Huntsman-Labed A; Day J
    Lancet; 2020 Sep; 396(10252):684-692. PubMed ID: 32891212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-Type Natriuretic Peptide Analogue Therapy in Children with Achondroplasia.
    Savarirayan R; Irving M; Bacino CA; Bostwick B; Charrow J; Cormier-Daire V; Le Quan Sang KH; Dickson P; Harmatz P; Phillips J; Owen N; Cherukuri A; Jayaram K; Jeha GS; Larimore K; Chan ML; Huntsman Labed A; Day J; Hoover-Fong J
    N Engl J Med; 2019 Jul; 381(1):25-35. PubMed ID: 31269546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth and growth hormone therapy in children with achondroplasia: a two-year experience.
    Stamoyannou L; Karachaliou F; Neou P; Papataxiarchou K; Pistevos G; Bartsocas CS
    Am J Med Genet; 1997 Oct; 72(1):71-6. PubMed ID: 9295079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lifetime impact of achondroplasia study in Europe (LIAISE): findings from a multinational observational study.
    Maghnie M; Semler O; Guillen-Navarro E; Selicorni A; Heath KE; Haeusler G; Hagenäs L; Merker A; Leiva-Gea A; González VL; Raimann A; Rehberg M; Santos-Simarro F; Ertl DA; Gregersen PA; Onesimo R; Landfeldt E; Jarrett J; Quinn J; Rowell R; Pimenta J; Cohen S; Butt T; Shediac R; Mukherjee S; Mohnike K
    Orphanet J Rare Dis; 2023 Mar; 18(1):56. PubMed ID: 36922864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth hormone treatment in 35 prepubertal children with achondroplasia: a five-year dose-response trial.
    Hertel NT; Eklöf O; Ivarsson S; Aronson S; Westphal O; Sipilä I; Kaitila I; Bland J; Veimo D; Müller J; Mohnike K; Neumeyer L; Ritzen M; Hagenäs L
    Acta Paediatr; 2005 Oct; 94(10):1402-10. PubMed ID: 16299871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A registry of achondroplasia: a 6-year experience from the Czechia and Slovak Republic.
    Pesl M; Verescakova H; Skutkova L; Strenkova J; Krejci P
    Orphanet J Rare Dis; 2022 Jun; 17(1):229. PubMed ID: 35710503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth references for height, weight, and head circumference for Argentine children with achondroplasia.
    del Pino M; Fano V; Lejarraga H
    Eur J Pediatr; 2011 Apr; 170(4):453-9. PubMed ID: 20938683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A height-for-age growth reference for children with achondroplasia: Expanded applications and comparison with original reference data.
    Hoover-Fong J; McGready J; Schulze K; Alade AY; Scott CI
    Am J Med Genet A; 2017 May; 173(5):1226-1230. PubMed ID: 28374958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and Exposure-Response of Vosoritide in Children with Achondroplasia.
    Chan ML; Qi Y; Larimore K; Cherukuri A; Seid L; Jayaram K; Jeha G; Fisheleva E; Day J; Huntsman-Labed A; Savarirayan R; Irving M; Bacino CA; Hoover-Fong J; Ozono K; Mohnike K; Wilcox WR; Horton WA; Henshaw J
    Clin Pharmacokinet; 2022 Feb; 61(2):263-280. PubMed ID: 34431071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Timing of puberty and physical growth in obese children: a longitudinal study in boys and girls.
    De Leonibus C; Marcovecchio ML; Chiavaroli V; de Giorgis T; Chiarelli F; Mohn A
    Pediatr Obes; 2014 Aug; 9(4):292-9. PubMed ID: 23713062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pubertal growth in height, sitting height and leg length in achondroplasia.
    Cole TJ; Del Pino M; Adamo P; Fano V
    Ann Hum Biol; 2021 Feb; 48(1):8-14. PubMed ID: 33533281
    [No Abstract]   [Full Text] [Related]  

  • 19. Final height after combined growth hormone and gonadotrophin-releasing hormone analogue therapy in short healthy children entering into normally timed puberty.
    Lanes R; Gunczler P
    Clin Endocrinol (Oxf); 1998 Aug; 49(2):197-202. PubMed ID: 9828907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth in achondroplasia including stature, weight, weight-for-height and head circumference from CLARITY: achondroplasia natural history study-a multi-center retrospective cohort study of achondroplasia in the US.
    Hoover-Fong JE; Schulze KJ; Alade AY; Bober MB; Gough E; Hashmi SS; Hecht JT; Legare JM; Little ME; Modaff P; Pauli RM; Rodriguez-Buritica DF; Serna ME; Smid C; Liu C; McGready J
    Orphanet J Rare Dis; 2021 Dec; 16(1):522. PubMed ID: 34949201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.